References
- Anderson , S. and Hauck , W. W. 1983 . “A New Procedure for Testing Equivalence in Comparative Bioavailability and Other Clinical Trials,” . Communications in Statistics, Part A–Theory and Methods , 12 : 2663 – 2692 .
- Archibald . 1900 . “Le Limaçon de Pascal,” . L'Intermediaire des Mathématiciens , : 106 – 107 .
- Berger , R. L. 1982 . “Multiparameter Hypothesis Testing and Acceptance Sampling,” . Technometrics , 24 : 295 – 300 .
- Bofinger , E. 1992 . “Expanded Confidence Intervals, One-Sided Tests, and Equivalence Testing,” . Journal of Biopharmacological Statistics , 2 ( 2 ) : 181 – 188 .
- Brown , L. D. and Fox , M. 1974 . “Admissibility in Statistical Problems Involving a Location or Scale Parameter,” . The Annals of Statistics, 2 , : 807 – 814 .
- Brown , L. D. and Sackrowitz , H. 1984 . “An Alternative to Student's t Test for Problems With Indifference Zones,” . The Annals of Statistics , 12 : 451 – 469 .
- Casella , G. and Berger , R. L. 1990 . Statistical Inference , Pacific Grove , CA : Wadsworth and Brooks/Cole .
- Casella , G. and Hwang , J. T. 1983 . “Empirical Bays Confidence Sets for the Mean of a Multivariate Normal Distribution,” . Journal of the American Statistical Association , 78 : 688 – 698 .
- Cohen , A. and Strawderman , W. E. 1973 . “Admissibility Implications for Different Criteria in Confidence Estimation,” . The Annals of Statistics , 1 : 363 – 366 .
- Crow , E. L. 1956 . “Confidence Intervals for a Proportion,” . Biometrika , 43 : 423 – 425 .
- U.S. Food and Drug Administration . 1992 . Draft Recommendation on Statistical Procedures for Bioequivalence Studies Using the Standard Two-Treatment Crossover Design , Rockville , MD : Center for Drug Evaluation and Research, Food and Drug Administration .
- Ghosh , J. K. 1961 . “On the Relation Among Shortest Confidence Intervals of Different Types,” . Calcutta Statistical Association Bulletin , : 147 – 152 .
- Hauck , W. W. and Anderson , S. 1984 . “A New Statistical Procedure for Testing Equivalence in Two-Group Comparative Bioavailability Trials,” . Journal of Pharmacokinetic Biopharmacology , 12 : 83 – 91 .
- Hauck , W. W. and Anderson , S. 1992 . “Types of Bioequivalence and Related Statistical Considerations,” . International Journal of Clinical Pharmacology and Therapeutic Toxicology , 30 : 181 – 187 .
- Hsu , J. C. 1981 . “Simultaneous Confidence Intervals for All Distances From the Best,” . The Annals of Statistics , 9 : 1026 – 1034 .
- Hsu , J. C. 1984 . “Constrained Two-Sided Simultaneous Confidence Intervals for Multiple Comparisons With the Best,” . The Annals of Statistics , 12 : 1136 – 1144 .
- Hsu , J. C. , Hwang , J. T. G. , Liu , H. K. and Ruberg , S. J. 1994 . “Equivalence Confidence Intervals in Bioequivalence Trials,” . Biometrika , 81 : 103 – 114 .
- Liu , H. K. “Confidence Intervals in Bioequivalence,” . Proceedings of the Biopharmacologv Section . pp. 51 – 54 . American Statistical Association .
- Metzler , C. M. 1974 . “Bioavailability–A Problem in Equivalence,” . Biometrics , 30 : 309 – 317 .
- Pratt , J. W. 1961 . “Length of Confidence Intervals,” . Journal of the American Statistical Association , 56 : 541 – 567 .
- Schuirmann , D. J. 1987 . “A Comparison of the Two One-Sided Test Procedures and the Power Approach for Assessing the Equivalence of Average Bioavailability,” . Journal of Pharmacology and Biopharmacology , 15 : 657 – 680 .
- Sheen , P-C , Kim , S-I. , Petillo , J. J. and Serajuddin , A. T. M. 1991 . “Bioavailability of a Poorly Water-Soluable Drug From Tablet and Solid Dispersion in Humans,” . Journal of Pharmacological Science , 80 : 712 – 714 .
- Shinozaki , N. 1989 . “Improved Confidence Sets for the Mean of a Multivariate Normal Distribution,” . Annals of the Institute of Statistical Mathematics , 41 : 331 – 346 .
- Sterne , T. E. 1954 . “Some Remarks on Confidence or Fiducial Limits,” . Biometrika , 41 : 275 – 278 .
- Tseng , Y. L. 1994 . “Good Exact Confidence Sets for a Multivariate Normal Mean,” , Ph.D. thesis Cornell University, Statistics Center .
- Westlake , W. J. 1972 . “Use of Confidence Intervals in Analysis of Comparative Bioavailability Trials,” . Journal of Pharmacological Science , 61 : 1340 – 1341 .
- Westlake , W. J. 1974 . “The Use of Balanced Incomplete Block Designs in Comparative Bioavailability Studies,” . Biometrics , 32 : 741 – 744 .
- Westlake , W. J. 1975 . “Statistical Problems in Interpreting Comparative Bioavailability Trials,” . International Journal of Chemical Pharmacology , 11 : 342 – 345 .
- Westlake , W. J. 1976 . “Symmetrical Confidence Intervals for Bioequivalence Trials,” . Biometrics , 32 : 741 – 744 .
- Westlake , W. J. 1979 . “Statistical Aspects of Comparative Bioavailbaility Trials,” . Biometrics , 35 : 273 – 280 .
- Westlake , W. J. 1981 . “Bioequivalence Testing–A Need to Rethink (Reader Reaction Response),” . Biometrics , 37 : 580 – 594 .